Squarepoint’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,756
| Closed | -$1.01M | – | 2873 |
|
|
2025
Q1 | $1.01M | Buy |
45,756
+19,398
| +74% | +$427K | ﹤0.01% | 1498 |
|
|
2024
Q4 | $704K | Buy |
26,358
+9,729
| +59% | +$260K | ﹤0.01% | 1750 |
|
|
2024
Q3 | $444K | Sell |
16,629
-35,912
| -68% | -$958K | ﹤0.01% | 1820 |
|
|
2024
Q2 | $946K | Buy |
52,541
+27,687
| +111% | +$499K | ﹤0.01% | 1398 |
|
|
2024
Q1 | $453K | Buy |
24,854
+13,244
| +114% | +$242K | ﹤0.01% | 1722 |
|
|
2023
Q4 | $127K | Buy |
+11,610
| New | +$127K | ﹤0.01% | 2231 |
|
|
2022
Q1 | – | Sell |
-12,197
| Closed | -$186K | – | 2410 |
|
|
2021
Q4 | $186K | Buy |
+12,197
| New | +$186K | ﹤0.01% | 2124 |
|
|
2021
Q2 | – | Sell |
-20,185
| Closed | -$656K | – | 2736 |
|
|
2021
Q1 | $656K | Buy |
+20,185
| New | +$656K | ﹤0.01% | 1353 |
|